Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachi Sakaguchi

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|March 31, 2010
Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropeniaSachi Sakaguchi, Masahiro Saito, Hirokazu Tsuji, et al.
Breast Cancer (Tokyo, Japan)|January 16, 2021
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in JapanYucherng Chen, Satoshi Noma, Yoshio Taguchi, et al.
Cancer Science|September 28, 2022
Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2Masakazu Toi, Chiun-Sheng Huang, Young-Hyuck Im, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 20, 2021
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α-fetoprotein: Outcomes by treatment-emergent ascitesMasatoshi Kudo, Masafumi Ikeda, Peter R Galle, et al.
Cancer Science|October 25, 2018
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcomaKan Yonemori, Makoto Kodaira, Taroh Satoh, et al.
Experimental Hematology|March 30, 2006
Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell developmentTomoko Taguchi, Hisami Takenouchi, Jun Matsui, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 15, 2014
Pain management during bone marrow aspiration and biopsy in pediatric cancer patientsYoko Kato, Miho Maeda, Yuki Aoki, et al.
British Journal of Haematology|October 15, 2013
Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort studyYasushi Ishida, Miho Maeda, Kevin Y Urayama, et al.
International Journal of Hematology|July 5, 2018
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in JapanTakashi Taga, Toshihiko Imamura, Kentaro Nakashima, et al.
Breast Cancer (Tokyo, Japan)|April 2, 2021
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapyKenichi Inoue, Norikazu Masuda, Hiroji Iwata, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|March 31, 2010
Bacterial rRNA-targeted reverse transcription-PCR used to identify pathogens responsible for fever with neutropeniaSachi Sakaguchi, Masahiro Saito, Hirokazu Tsuji, et al.
Breast Cancer (Tokyo, Japan)|January 16, 2021
Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in JapanYucherng Chen, Satoshi Noma, Yoshio Taguchi, et al.
Cancer Science|September 28, 2022
Abemaciclib plus fulvestrant in East Asian women with HR+, HER2- advanced breast cancer: Overall survival from MONARCH 2Masakazu Toi, Chiun-Sheng Huang, Young-Hyuck Im, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 20, 2021
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α-fetoprotein: Outcomes by treatment-emergent ascitesMasatoshi Kudo, Masafumi Ikeda, Peter R Galle, et al.
Cancer Science|October 25, 2018
Phase 1 study of olaratumab plus doxorubicin in Japanese patients with advanced soft-tissue sarcomaKan Yonemori, Makoto Kodaira, Taroh Satoh, et al.
Experimental Hematology|March 30, 2006
Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro-B-cell developmentTomoko Taguchi, Hisami Takenouchi, Jun Matsui, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|January 15, 2014
Pain management during bone marrow aspiration and biopsy in pediatric cancer patientsYoko Kato, Miho Maeda, Yuki Aoki, et al.
British Journal of Haematology|October 15, 2013
Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort studyYasushi Ishida, Miho Maeda, Kevin Y Urayama, et al.
International Journal of Hematology|July 5, 2018
Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in JapanTakashi Taga, Toshihiko Imamura, Kentaro Nakashima, et al.
Breast Cancer (Tokyo, Japan)|April 2, 2021
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapyKenichi Inoue, Norikazu Masuda, Hiroji Iwata, et al.
Pageof 3